"Yayoi Kawata,Taisuke Ichimaru,Masakazu Kogami,Kota Kodama,Shuto Miyashita,Shintaro Sengoku","Multi-layer platform coordination for open innovation in oligonucleotide therapeutics",,"Drug Discovery Today","Elsevier Current Trends","Vol. 30","No. 2",,2025,Jan.
"Hiromu Yoshiura,Yayoi Kawata,Shintaro Sengoku","Open Innovation and regulatory challenges in new modality development: the pivotal role of contract development and manufacturing organisations in advancing antibody drugs",,"Therapeutic Innovation & Regulatory Science","Springer International Publishing","Vol. 59","No. 1","pp. 63-70",2024,Oct.
"川田 弥生,伊波 興一朗,梅田 佳実,仙石 愼太郎","技術プラットフォームに基づくバイオテック企業の価値形成モデル -ペプチドリーム社の事例-",,"日本知財学会誌","日本知財学会","Vol. 19","No. 1","pp. 58-73",2022,Oct.
"Yayoi Kawata,Kota Kodama,Shintaro Sengoku","Effect of external innovation on advanced pharmaceutical R&D: The case of monoclonal antibody drug development","2022 Portland International Conference on Management of Engineering and Technology (PICMET)","Proceedings of PICMET'22 Conference: Portland International Center for Management of Engineering and Technology","IEEE",,,,2022,Sept.
"Yayoi Kawata","Relationship between Technological Development and Open Innovation in the Pharmaceutical Industry",,,,,,,,
"Yayoi Kawata","Relationship between Technological Development and Open Innovation in the Pharmaceutical Industry",,,,,,,,
"Yayoi Kawata","Relationship between Technological Development and Open Innovation in the Pharmaceutical Industry",,,,,,,,